Education
About Us
Working with TipRanks
Follow Us
David Wichmann Insider Profile
4 Followers
David Wichmann, CEO, Director at UnitedHealth, holds 17.31K shares in Privia Health Group (Ticker: PRVA), holds 39.50K shares in Boston Scientific (Ticker: BSX), holds 968.11K shares in UnitedHealth (Ticker: UNH).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+7.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Wichmann holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Wichmann
David Wichmann's Trading History
UnitedHealth
Dec 17, 2020
CEO, Director
Uninformative Buy
―
$477.74M
Boston Scientific
May 13, 2024
Director
Uninformative Buy
―
$3.92M
Privia Health Group
May 23, 2024
Director
Uninformative Buy
―
$442.17K
Tennant Co
May 13, 2020
Director
Uninformative Buy
―
$1.27M
List of latest transactions for each holding click on a transaction to see David Wichmann's performance on stock
You May Also Like
David Wichmann insider profile FAQ
What is the percentage of profitable transactions made by David Wichmann?
The percentage of profitable transactions made by David Wichmann is 67%.
What is the average return per transaction made by David Wichmann?
The average return per transaction made by David Wichmann is 7.70%.
What stocks does David Wichmann hold?
David Wichmann holds: UNH, BSX, PRVA, TNC stocks.
What was David Wichmann’s latest transaction?
David Wichmann latest transaction was an Uninformative Buy of ―.
What was David Wichmann's most profitable transaction?
David Wichmann’s most profitable transaction was an Informative Buy of UNH stock on May 6, 2019. The return on the trade was 22.10%.
What is David Wichmann's role in UnitedHealth?
David Wichmann's role in UnitedHealth is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.